Ask your pharmacy whether they are a 503A or 503B facility, whether they comply with current USP 797 standards, and whether they have conducted stability testing specific to their tirzepatide formulation
Where we go from here Whatever happens, the EVOKE trials are going to change how we think about metabolism and inflammation in neurodegenerative conditions
171181, doi:10.1038/nrn2092 (englisch, Online)
Understanding the difference between common injection site irritation and genuine allergic reactions is essential for patient safety
Ferroptosis, first described by Dixon in 2012 as an iron-dependent regulated form of cell death, has emerged as a critical determinant of cellular fate across diverse physiological and pathological contexts (1)
Refyne can be injected nearly anywhere - but the best use cases are areas where the filler needs to be placed closer to the surface of the skin, and the area is subjected to a lot of movement